Medical School Researchers Make Strides Towards Approval of New Cyanide Treatment

Published by
Published by: 
Naomi McDonald, Director of Communications
May 25, 2017

Congratulations to Dr. Kumar Belani, Dr. Navneet Kaur and Dr. David Beebe from the Department of Anesthesiology on the recent publication of their study Pharmacokinetics of next generation cyanide antidote sulfanegen in rabbit.

The co-authored research published in the International Journal of Pharmacokinetics showed sulfanegen is rapidly absorbed and distributed throughout the body while the elimination of 3-MP was just as rapid. This research concluded that the PK characteristics of sulfanegen were found to be a suitable fit for the swift treatment of cyanide poisoning.

This research supports sulfanegen as a cyanide antidote and the FDA approval of sulfanegen as a necessary antidote.

Read the complete study.  

Share this post

You may also like:

We are proud to have honored our distinguished and talented faculty at the Medical School Promotion and Tenure Reception.

Internationally recognized Anesthesiology faculty was recently featured in Le Monde, a prestigious French newspaper.

How an ancient Egyptian arthritis remedy may soon be the next therapy for pulmonary arterial hypertension